ALEC vs CTAS · rev $4.4M vs P/E 51, rev $11.26B
Alector Inc (ALEC) versus Cintas Corporation (CTAS) — a side-by-side from cached financials, not a winner call.
Alector Inc (ALEC) is a biotechnology company listed on US.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Latest reported ALEC revenue for 2026-06-30 was $4.4M. Net income was -$45.9M. ALEC currently screens at market cap $216.5M.
Latest reported CTAS revenue for 2026-05-31 was $11.26B. Net income was $2.00B. Revenue was up 8.9% from 2025-05-31 to 2026-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
ALEC currently screens at market cap $216.5M. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Not investment advice. Open the ALEC and CTAS stock pages for the full models.
Not investment advice.